JOINT FILING AGREEMENT
Exhibit 99.2
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the Common Stock, $0.0001 par value per share, of Sensei Biotherapeutics, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: July 19, 2022
| Presight Sensei Co-Invest Fund, L.P. | |||
| By: | Presight Sensei Co-Invest Management, L.L.C., its general partner | ||
| By: | /s/ Fabian Xxxxxxxx Xxxxxx | ||
| Name: | Fabian Xxxxxxxx Xxxxxx | ||
| Title: | Managing Member | ||
| Presight Sensei Co-Invest Management, L.L.C. | |||
| By: | /s/ Fabian Xxxxxxxx Xxxxxx | ||
| Name: | Fabian Xxxxxxxx Xxxxxx | ||
| Title: | Managing Member | ||
| Apeiron Investment Group, Ltd. | |||
| By: | /s/ Xxxxxx Xxxxxx | ||
| Name: | Xxxxxx Xxxxxx | ||
| Title: | Director | ||
| /s/ Xxxxxxxxx Xxxxxxxxxx | |
| Xxxxxxxxx Xxxxxxxxxx |
